Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
Publié dansOncoImmunology, vol. 7, no. 12, e1501137
Date de publication2018
Résumé
Mots-clés
- GL261
- Glioblastoma
- Immune checkpoint blockade
- Mutational load
- SB28
Groupe de recherche
Financement
- Autre - Nuovo Soldati foundation for cancer research (V.G.), National Institute of Neurological Disorders and Stroke/National Institutes of Health (R35 NS105068) (H.O.), the Fondation Privée des HUG (P.W.) and the Association Frédéric Fellay (P.W. and P.Y.D.)
Citation (format ISO)
GENOUD, Vassilis et al. Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models. In: OncoImmunology, 2018, vol. 7, n° 12, p. e1501137. doi: 10.1080/2162402X.2018.1501137
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:124211
- DOI : 10.1080/2162402X.2018.1501137
- PMID : 30524896
URL commercialhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279422/
ISSN du journal2162-4011